Eligo Bioscience
PrivateLast Round
Grant
May 13, 2025
Total Funding Raised
$65.34M
Company Overview
Eligo Bioscience is a biotechnology company that develops in vivo gene editing technologies to modulate the microbiome for the treatment of bacteria-associated diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eligo Bioscience Comparables
Compare Eligo Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SNIPR Biome | 88% | |
| Locus Biosciences | 85% | |
| Nemesis Bioscience | 83% | |
Eligo Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 13, 2025 | ||||
| Series B | Dec 5, 2023 | ||||
| Grant | May 1, 2019 | ||||
| Series A | Sep 26, 2017 | ||||
| Seed | Jul 8, 2015 |
Key People
Founding team and executive leadership
Eligo Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Series B, Series A |
| European Commission | Grant |
| Bpifrance | Series B, Grant |
| Government of France | Grant |
| Sanofi Ventures | Series B |
| Bpifrance | Grant |
| Seventure Partners | Series A, Series B, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2025
Recognized as one of the World Economic Forum’s 30 Most Innovative Companies.
- May 13, 2025
Partnered with Biose Industries for microbial fermentation.
Eligo Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eligo Bioscience's valuation, stock price, and market status.